Browse our articles
Browse by:
Drug donanemab hailed as breakthrough in treating Alzheimer’s disease following trial
A new drug has been hailed as a scientific breakthrough in treating Alzheimer’s disease
South London researcher uses Join Dementia Research to boost recruitment
A researcher at King’s College London, spoke about using Join Dementia Research
Ten years in dementia research: Geoff and Susie’s story
A husband and wife who received a dementia diagnosis decided to take part in dementia research
Grandson calls for south London volunteers for dementia research
Grandson calls for south London volunteers for dementia research
New Alzheimer's drug slows cognitive decline by 35 per cent
Donanemab has been shown to reduce cognitive decline in people with early-stage Alzheimer’s disease.
Nine in ten people want to know their brain disease risk
New research reveals that 91 per cent of people would take a simple test to learn about their risk
